$4.49 Billion is the total value of Cormorant Asset Management, LP's 120 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $441,880,000 | +350.8% | 2,000,000 | +300.0% | 9.84% | +321.9% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $396,330,000 | +112.0% | 1,000,000 | +100.0% | 8.83% | +98.5% |
| AVIR | ATEA PHARMACEUTICALS INC | $395,901,000 | +52.4% | 6,411,355 | 0.0% | 8.82% | +42.6% | |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $260,122,000 | -10.8% | 2,750,000 | +15.0% | 5.80% | -16.5% |
| DSGN | New | DESIGN THERAPEUTICS INC | $146,409,000 | – | 5,114,850 | +100.0% | 3.26% | – |
| XBI | Sell | SPDR SER TRput | $135,650,000 | -35.8% | 1,000,000 | -33.3% | 3.02% | -39.9% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $133,605,000 | -17.1% | 2,168,909 | -4.3% | 2.98% | -22.4% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $132,254,000 | -15.0% | 4,720,000 | +5.8% | 2.95% | -20.5% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $115,847,000 | +17.3% | 2,525,000 | +1.2% | 2.58% | +9.8% |
| BCAB | Sell | BIOATLA INC | $109,927,000 | +45.8% | 2,192,060 | -4.4% | 2.45% | +36.4% |
| OLMA | OLEMA PHARMACEUTICALS INC | $105,084,000 | -29.1% | 3,195,544 | 0.0% | 2.34% | -33.6% | |
| CCCC | C4 THERAPEUTICS INC | $92,107,000 | +15.1% | 2,490,065 | 0.0% | 2.05% | +7.8% | |
| APLS | APELLIS PHARMACEUTICALS INC | $80,075,000 | -25.0% | 1,866,108 | 0.0% | 1.78% | -29.8% | |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $74,307,000 | – | 2,340,914 | +100.0% | 1.66% | – |
| ALXO | ALX ONCOLOGY HLDGS INC | $65,022,000 | -14.5% | 881,770 | 0.0% | 1.45% | -19.9% | |
| ZYME | Buy | ZYMEWORKS INC | $63,160,000 | +11.4% | 2,000,000 | +66.7% | 1.41% | +4.2% |
| RCKT | ROCKET PHARMACEUTICALS INC | $60,723,000 | -19.1% | 1,368,550 | 0.0% | 1.35% | -24.2% | |
| OMER | Sell | OMEROS CORP | $58,741,000 | +2.8% | 3,300,030 | -17.5% | 1.31% | -3.8% |
| STOK | STOKE THERAPEUTICS INC | $55,844,000 | -37.3% | 1,437,807 | 0.0% | 1.24% | -41.3% | |
| TARS | TARSUS PHARMACEUTICALS INC | $55,251,000 | -21.0% | 1,714,269 | 0.0% | 1.23% | -26.1% | |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $53,752,000 | -14.5% | 2,464,545 | -0.0% | 1.20% | -20.0% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $50,400,000 | – | 2,000,000 | +100.0% | 1.12% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $47,108,000 | -34.0% | 275,000 | -15.4% | 1.05% | -38.3% |
| NVAX | New | NOVAVAX INC | $45,328,000 | – | 250,000 | +100.0% | 1.01% | – |
| CCXI | Sell | CHEMOCENTRYX INC | $43,554,000 | -41.4% | 850,000 | -29.2% | 0.97% | -45.1% |
| AXNX | AXONICS MODULATION TECHNOLOG | $41,504,000 | +20.0% | 693,000 | 0.0% | 0.92% | +12.4% | |
| New | DERMTECH INC | $40,632,000 | – | 800,000 | +100.0% | 0.90% | – | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $39,880,000 | -35.5% | 400,000 | -20.0% | 0.89% | -39.6% |
| IGMS | Sell | IGM BIOSCIENCES INC | $38,021,000 | -28.2% | 495,769 | -17.4% | 0.85% | -32.8% |
| XLRN | Sell | ACCELERON PHARMA INC | $37,293,000 | -31.4% | 275,000 | -35.3% | 0.83% | -35.8% |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $37,195,000 | -54.8% | 1,230,000 | -26.0% | 0.83% | -57.7% |
| LBPH | New | LONGBOARD PHARMACEUTICALS IN | $37,193,000 | – | 2,356,000 | +100.0% | 0.83% | – |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $36,623,000 | – | 2,098,024 | +100.0% | 0.82% | – |
| PRAX | PRAXIS PRECISION MEDICINES I | $35,189,000 | -39.1% | 1,074,145 | 0.0% | 0.78% | -42.9% | |
| VERU | New | VERU INC | $32,325,000 | – | 3,000,000 | +100.0% | 0.72% | – |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $28,815,000 | -16.4% | 1,267,167 | +0.0% | 0.64% | -21.8% |
| MASS | 908 DEVICES INC | $25,919,000 | -12.1% | 545,322 | 0.0% | 0.58% | -17.8% | |
| NTLA | INTELLIA THERAPEUTICS INCput | $24,075,000 | +47.5% | 300,000 | 0.0% | 0.54% | +38.1% | |
| PLRX | PLIANT THERAPEUTICS INC | $24,047,000 | +73.1% | 611,409 | 0.0% | 0.54% | +61.9% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $24,035,000 | -4.8% | 247,200 | +9.9% | 0.54% | -11.0% |
| New | APTOSE BIOSCIENCES INC | $23,900,000 | – | 4,000,000 | +100.0% | 0.53% | – | |
| PHVS | New | PHARVARIS N V | $23,811,000 | – | 864,143 | +100.0% | 0.53% | – |
| TWST | Sell | TWIST BIOSCIENCE CORP | $22,914,000 | -27.9% | 185,000 | -17.8% | 0.51% | -32.6% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $22,742,000 | -26.0% | 2,750,000 | -38.9% | 0.51% | -30.6% |
| MORF | Buy | MORPHIC HLDG INC | $22,148,000 | +230.1% | 350,000 | +75.0% | 0.49% | +208.1% |
| SBTX | SILVERBACK THERAPEUTICS INC | $21,815,000 | -5.8% | 500,000 | 0.0% | 0.49% | -11.8% | |
| AKRO | AKERO THERAPEUTICS INC | $21,541,000 | +12.4% | 742,549 | 0.0% | 0.48% | +5.3% | |
| CABA | CABALETTA BIO INC | $21,139,000 | -11.1% | 1,904,424 | 0.0% | 0.47% | -16.8% | |
| AGEN | Buy | AGENUS INC | $21,080,000 | -5.3% | 7,750,000 | +10.7% | 0.47% | -11.3% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $20,580,000 | -56.2% | 1,000,000 | -41.2% | 0.46% | -59.0% |
| ZLAB | Sell | ZAI LAB LTDadr | $20,014,000 | -21.8% | 150,000 | -20.7% | 0.45% | -26.8% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $19,872,000 | +28.5% | 900,000 | +80.0% | 0.44% | +20.4% |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $19,268,000 | – | 750,000 | +100.0% | 0.43% | – |
| HGEN | New | HUMANIGEN INC | $19,100,000 | – | 1,000,000 | +100.0% | 0.43% | – |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $18,500,000 | – | 1,000,000 | +100.0% | 0.41% | – |
| OMER | OMEROS CORPcall | $17,800,000 | +24.6% | 1,000,000 | 0.0% | 0.40% | +16.8% | |
| ALBO | ALBIREO PHARMA INC | $17,625,000 | -6.0% | 500,000 | 0.0% | 0.39% | -11.9% | |
| INSP | Sell | INSPIRE MED SYS INC | $17,594,000 | -6.5% | 85,000 | -15.0% | 0.39% | -12.5% |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $15,146,000 | – | 1,415,500 | +100.0% | 0.34% | – |
| RPTX | Buy | REPARE THERAPEUTICS INC | $14,185,000 | +37.9% | 462,205 | +54.1% | 0.32% | +29.0% |
| ANAB | ANAPTYSBIO INC | $14,008,000 | +0.2% | 650,000 | 0.0% | 0.31% | -6.3% | |
| BEAM | Sell | BEAM THERAPEUTICS INC | $13,749,000 | -81.8% | 171,775 | -81.4% | 0.31% | -83.0% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $13,670,000 | -62.5% | 200,000 | -52.9% | 0.30% | -64.8% |
| FHTX | FOGHORN THERAPEUTICS INC | $13,180,000 | -35.0% | 1,000,000 | 0.0% | 0.29% | -39.0% | |
| GLTO | GALECTO INC | $13,066,000 | -50.6% | 2,150,732 | 0.0% | 0.29% | -53.8% | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $12,888,000 | -22.7% | 100,000 | 0.0% | 0.29% | -27.7% | |
| HARP | HARPOON THERAPEUTICS INC | $11,937,000 | +25.9% | 570,600 | 0.0% | 0.27% | +17.7% | |
| AXSM | AXSOME THERAPEUTICS INC | $11,324,000 | -30.5% | 200,000 | 0.0% | 0.25% | -35.1% | |
| TBPH | THERAVANCE BIOPHARMA INC | $11,226,000 | +14.9% | 550,000 | 0.0% | 0.25% | +7.3% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $10,980,000 | – | 1,500,000 | +100.0% | 0.24% | – |
| BNTX | Sell | BIONTECH SEsponsored ads | $10,919,000 | -51.3% | 100,000 | -63.6% | 0.24% | -54.4% |
| ITOS | ITEOS THERAPEUTICS INC | $10,254,000 | +1.1% | 300,000 | 0.0% | 0.23% | -5.4% | |
| INSM | INSMED INC | $10,218,000 | +2.3% | 300,000 | 0.0% | 0.23% | -4.2% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $9,196,000 | +1.4% | 125,000 | 0.0% | 0.20% | -5.1% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $8,984,000 | -12.3% | 800,000 | 0.0% | 0.20% | -18.0% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $8,968,000 | -21.4% | 200,000 | 0.0% | 0.20% | -26.5% | |
| BCTG | BCTG ACQUISITION CORP | $8,896,000 | -2.8% | 800,000 | 0.0% | 0.20% | -9.2% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,676,000 | +4.7% | 200,000 | 0.0% | 0.19% | -2.0% | |
| QURE | UNIQURE NV | $8,422,000 | -6.8% | 250,000 | 0.0% | 0.19% | -12.6% | |
| ARGX | ARGENX SEsponsored adr | $8,262,000 | -6.4% | 30,000 | 0.0% | 0.18% | -12.4% | |
| GOSS | GOSSAMER BIO INC | $7,848,000 | -4.3% | 848,382 | 0.0% | 0.18% | -10.3% | |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $7,672,000 | – | 459,144 | +100.0% | 0.17% | – |
| MRUS | MERUS N V | $7,311,000 | +19.1% | 350,000 | 0.0% | 0.16% | +11.6% | |
| MGTA | New | MAGENTA THERAPEUTICS INC | $7,104,000 | – | 600,000 | +100.0% | 0.16% | – |
| AKUS | Sell | AKOUOS INC | $6,935,000 | -30.1% | 499,989 | -0.0% | 0.15% | -34.7% |
| GMTX | New | GEMINI THERAPEUTICS INC | $6,436,000 | – | 475,000 | +100.0% | 0.14% | – |
| GTH | Sell | GENETRON HLDGS LTDads | $6,438,000 | +15.0% | 300,000 | -25.0% | 0.14% | +7.5% |
| CGEM | New | CULLINAN ONCOLOGY INC | $6,250,000 | – | 150,000 | +100.0% | 0.14% | – |
| QTNT | QUOTIENT LTD | $5,520,000 | -29.4% | 1,500,000 | 0.0% | 0.12% | -33.9% | |
| TARA | PROTARA THERAPEUTICS INC | $5,509,000 | -35.0% | 350,000 | 0.0% | 0.12% | -39.1% | |
| IMVT | Sell | IMMUNOVANT INC | $5,406,000 | -92.5% | 337,048 | -78.4% | 0.12% | -93.0% |
| BLSA | BCLS ACQUISITION CORP | $5,285,000 | -4.1% | 500,000 | 0.0% | 0.12% | -9.9% | |
| RACA | THERAPEUTICS ACQUISITION COR | $5,255,000 | -24.7% | 500,000 | 0.0% | 0.12% | -29.5% | |
| SRPT | SAREPTA THERAPEUTICS INC | $5,217,000 | -56.3% | 70,000 | 0.0% | 0.12% | -59.2% | |
| FVAM | 5 01 ACQUISITION CORP | $4,988,000 | -1.9% | 500,000 | 0.0% | 0.11% | -8.3% | |
| VSPRU | VESPER HEALTHCARE ACQSTN CORunit 99/99/9999 | $4,620,000 | -4.7% | 400,000 | 0.0% | 0.10% | -10.4% | |
| BCEL | ATRECA INC | $4,499,000 | -5.1% | 293,500 | 0.0% | 0.10% | -11.5% | |
| HLXA | HELIX ACQUISITION CORP | $4,386,000 | -7.5% | 430,000 | 0.0% | 0.10% | -13.3% | |
| REPL | REPLIMUNE GROUP INC | $3,814,000 | -20.0% | 125,000 | 0.0% | 0.08% | -24.8% | |
| TIL | New | INSTIL BIO INC | $3,762,000 | – | 150,000 | +100.0% | 0.08% | – |
| DTIL | PRECISION BIOSCIENCES INC | $3,587,000 | +24.1% | 346,524 | 0.0% | 0.08% | +15.9% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $3,540,000 | -28.0% | 400,000 | 0.0% | 0.08% | -32.5% | |
| KDMN | Sell | KADMON HLDGS INC | $2,918,000 | -17.3% | 750,000 | -11.8% | 0.06% | -22.6% |
| ALLK | Sell | ALLAKOS INC | $2,870,000 | -59.0% | 25,000 | -50.0% | 0.06% | -61.7% |
| NUVB | New | NUVATION BIO INC | $2,450,000 | – | 234,445 | +100.0% | 0.06% | – |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $2,419,000 | -35.9% | 422,167 | 0.0% | 0.05% | -40.0% | |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $2,406,000 | – | 130,000 | +100.0% | 0.05% | – |
| TCDA | TRICIDA INC | $2,264,000 | -25.0% | 427,975 | 0.0% | 0.05% | -30.6% | |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $1,925,000 | – | 125,000 | +100.0% | 0.04% | – |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,863,000 | +68.0% | 256,649 | 0.0% | 0.04% | +61.5% | |
| CRDF | CARDIFF ONCOLOGY INC | $1,389,000 | -48.5% | 150,000 | 0.0% | 0.03% | -51.6% | |
| ARNA | ARENA PHARMACEUTICALS INC | $1,388,000 | -9.7% | 20,000 | 0.0% | 0.03% | -16.2% | |
| XFOR | X4 PHARMACEUTICALS INC | $895,000 | +33.8% | 103,980 | 0.0% | 0.02% | +25.0% | |
| FATE | FATE THERAPEUTICS INC | $824,000 | -9.4% | 10,000 | 0.0% | 0.02% | -18.2% | |
| IMV | IMV INC | $772,000 | +7.8% | 234,374 | 0.0% | 0.02% | 0.0% | |
| NERV | MINERVA NEUROSCIENCES INC | $584,000 | +24.8% | 200,000 | 0.0% | 0.01% | +18.2% | |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $563,000 | -25.2% | 133,331 | 0.0% | 0.01% | -27.8% | |
| OTLKW | New | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $421,000 | – | 416,666 | +100.0% | 0.01% | – |
| NKTR | Sell | NEKTAR THERAPEUTICS | $400,000 | -41.2% | 20,000 | -50.0% | 0.01% | -43.8% |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $222,000 | – | 83,332 | +100.0% | 0.01% | – |
| MGEN | Exit | MIRAGEN THERAPEUTICS INC | $0 | – | -93,126 | -100.0% | -0.04% | – |
| PANAU | Exit | PANACEA ACQUISITION CORPunit 99/99/9999 | $0 | – | -250,000 | -100.0% | -0.08% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -244,032 | -100.0% | -0.08% | – |
| FSDC | Exit | FS DEV CORP | $0 | – | -500,000 | -100.0% | -0.13% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -2,600,000 | -100.0% | -0.40% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -650,000 | -100.0% | -0.50% | – |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -1,415,500 | -100.0% | -0.51% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -200,000 | -100.0% | -0.73% | – |
| VIE | Exit | VIELA BIO INC | $0 | – | -1,429,200 | -100.0% | -1.22% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -750,000 | -100.0% | -5.60% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.